Top compounds associated with response to IRX4


Feature Type Standardized
Nominal ANOVA
mRNA brivanib CTRPv2 pan-cancer AAC 0.021 0.6
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC 0.022 0.6
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.021 0.6
mRNA Vandetanib FIMM pan-cancer AAC -0.098 0.6
mRNA SB590885 GDSC1000 pan-cancer AAC -0.019 0.6
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA AP-24534 FIMM pan-cancer AAC 0.092 0.6
Download CSV